Wegovy Reduces Stroke and Heart Attack Risks, Claims Company
Novo Nordisk's obesity drug Wegovy reduces the risk of cardiovascular events by 20%, offering medical benefits beyond weight reduction.
Liver disease News & Breaking Stories
Get Weekly News Updates
Subscribe to SHUT Newsletter and be up to date with the current events. Be informed, don't settle for fake news.